Lipid-lowering drug use is associated with reduced prevalence of atrial fibrillation in patients with left ventricular systolic dysfunction
- 11 May 2006
- journal article
- research article
- Published by Elsevier
- Vol. 3 (8) , 881-886
- https://doi.org/10.1016/j.hrthm.2006.05.010
Abstract
No abstract availableKeywords
This publication has 41 references indexed in Scilit:
- The Relationship Between Stature and the Prevalence of Atrial Fibrillation in Patients With Left Ventricular DysfunctionJournal of the American College of Cardiology, 2006
- Acute Antiinflammatory Properties of Statins Involve Peroxisome Proliferator–Activated Receptor-α via Inhibition of the Protein Kinase C Signaling PathwayCirculation Research, 2006
- C reactive protein concentration and recurrence of atrial fibrillation after electrical cardioversionHeart, 2005
- A Myocardial Nox2 Containing NAD(P)H Oxidase Contributes to Oxidative Stress in Human Atrial FibrillationCirculation Research, 2005
- Novel Roles for Nox Oxidases in Cardiac Arrhythmia and Oxidized Glutathione Export in Endothelial FunctionCirculation Research, 2005
- The effects of steroids on the occurrence of postoperative atrial fibrillation after coronary artery bypass grafting surgery: A prospective randomized trialThe Journal of Thoracic and Cardiovascular Surgery, 2005
- Oral vitamin C administration reduces early recurrence rates after electrical cardioversion of persistent atrial fibrillation and attenuates associated inflammationInternational Journal of Cardiology, 2005
- Effect of Simvastatin and Antioxidant Vitamins on Atrial Fibrillation Promotion by Atrial-Tachycardia Remodeling in DogsCirculation, 2004
- Evidence for anti-inflammatory activity of statins and PPARα activators in human C-reactive protein transgenic mice in vivo and in cultured human hepatocytes in vitroBlood, 2004
- Analysis of pravastatin to prevent recurrence of atrial fibrillation after electrical cardioversionThe American Journal of Cardiology, 2004